OneVentures has been absolutely foundational to our success. 

It’s not just bringing money to the table. It’s bringing support, emotional support, strategic support, and a team of people who stand behind the brand. And, without OneVentures, I don’t think we’d be where we are today.

OneVentures has been terrific to work with as a lead investor, but it’s what they add in addition to investment that has been critical to Vaxxas’ growth.

Working with the OneVentures team has translated into sharpening all aspects of our development and commercialisation strategy and actively helped us forge connections and partners with industry.

From day one, OneVentures really rolled up their sleeves and became true partners in the business. They brought a mix of strategic insight, operational know-how, and a strong network that helped us make some big decisions early on, from restructuring to scaling for growth. It always felt like they were in our corner, and it’s been a great partnership all the way through.

OneVentures are a unique, one-of-a-kind investor in the venture capital world. Their unyielding support has allowed our organisation to pursue our dream of developing a practical replacement to the failing human heart. Without the OneVentures team, we would not be where we are today!

We chose growth credit to support our global growth strategy. OneVentures understood our objectives and moved quickly to execute our plans, structuring the facility in tranches to minimise interest payments and maintain control over our cash flow, while allowing us to scale our financing up or down in response to uncertain M&A outcomes.

OneVentures’ contribution to ImmVirX has extended well beyond capital. I would recommend them to any life sciences company looking for an investor that brings real sector expertise and a genuine willingness to contribute over the long term.